Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Picker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Immunology|July 23, 2017
CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccinationKlaus Früh, Louis Picker
Nature Medicine|January 9, 2013
Roadblocks to translational challenges on viral pathogenesisSteven Deeks, Christian Drosten, Louis Picker, et al.
Vaccine|May 2, 2002
Analysis of the immune response and viral evolution during the acute phase of SIV infectionHelen Horton, Thorsten Vogel, David O'Connor, et al.
Journal of Immunological Methods|September 30, 2010
Naïve and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligationDavid Kuhrt, Seth Faith, Angela Hattemer, et al.
Molecular Cancer Therapeutics|March 17, 2018
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion ProteinMichael D Oberst, Catherine Augé, Chad Morris, et al.
Research Square|July 17, 2025
Identification of initial sites of SIV rebound after treatment cessationLouis Picker, Brandon Keele, Afam Okoye, et al.
Plos Pathogens|February 22, 2019
Casting a wider net: Immunosurveillance by nonclassical MHC moleculesM Patricia D'Souza, Erin Adams, John D Altman, et al.
Cell|December 11, 2020
The Identity of Human Tissue-Emigrant CD8<sup>+</sup> T CellsMarcus Buggert, Laura A Vella, Son Nguyen, et al.
Science (New York, N.Y.)|December 18, 2020
Sequence diversity analyses of an improved rhesus macaque genome enhance its biomedical utilityWesley C Warren, R Alan Harris, Marina Haukness, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Immunology|July 23, 2017
CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccinationKlaus Früh, Louis Picker
Nature Medicine|January 9, 2013
Roadblocks to translational challenges on viral pathogenesisSteven Deeks, Christian Drosten, Louis Picker, et al.
Vaccine|May 2, 2002
Analysis of the immune response and viral evolution during the acute phase of SIV infectionHelen Horton, Thorsten Vogel, David O'Connor, et al.
Journal of Immunological Methods|September 30, 2010
Naïve and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligationDavid Kuhrt, Seth Faith, Angela Hattemer, et al.
Molecular Cancer Therapeutics|March 17, 2018
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion ProteinMichael D Oberst, Catherine Augé, Chad Morris, et al.
Research Square|July 17, 2025
Identification of initial sites of SIV rebound after treatment cessationLouis Picker, Brandon Keele, Afam Okoye, et al.
Plos Pathogens|February 22, 2019
Casting a wider net: Immunosurveillance by nonclassical MHC moleculesM Patricia D'Souza, Erin Adams, John D Altman, et al.
Cell|December 11, 2020
The Identity of Human Tissue-Emigrant CD8<sup>+</sup> T CellsMarcus Buggert, Laura A Vella, Son Nguyen, et al.
Science (New York, N.Y.)|December 18, 2020
Sequence diversity analyses of an improved rhesus macaque genome enhance its biomedical utilityWesley C Warren, R Alan Harris, Marina Haukness, et al.
Pageof 1